Completed Infection & Immunity Food & Agriculture

Improved control of endemic foot-and-mouth disease by development of virus like particle vaccines

In plain English

AI plain-English summary

Foot-and-mouth disease vaccines made from killed virus require high-containment facilities and protect livestock for only a short time against a narrow range of viral strains. This project aims to replace those vaccines with synthetic virus-like particles grown in insect cells—a safer, cheaper, and more adaptable platform. The problem is that current vaccines are a major constraint on global livestock trade. Outbreaks cause enormous economic losses, but the vaccines themselves are expensive to produce and offer limited, short-lived immunity. Farmers in endemic regions often cannot afford repeated vaccination, leaving herds vulnerable. If successful, this new platform would allow researchers to engineer the viral capsid—the protein shell that triggers immunity—to stimulate longer-lasting antibody responses and protect against many viral strains at once. That could reduce the frequency of vaccination, lower costs, and make international trade in livestock products less risky. The work is applied vaccine development with a clear practical endpoint: better control of a devastating animal disease in the field.

View original technical description
Foot-and-mouth disease (FMD) is a highly contagious, acute viral disease of clovenhoofed, domesticated and wild animals. The disease is much feared as the virus can spread extremely rapidly, has the potential to cause enormous economic losses and is the single most important constraint to international trade in livestock and animal products. Current vaccines are made of inactivated virus and induce a protective antibody response but only for a short duration and only against viruses that are closely related to the vaccine strain. We have developed methods to produce stabilised FMDV capsids in insect cells which do not require expensive high disease containment facilities. This new capsid production platform will allow modification of the structures to enhance the short duration of immunity and the narrow spectrum of the protective immune responses. We will identify methods to enhance the cellular immune responses to the capsids and so stimulate prolonged antibody responses. In addition we will establish which parts of the viral capsid structure are the most important to use in new vaccines to protect against a wide range of viruses. Once identified these common structures can be engineered for enhanced prominence in new vaccines designed to induce widely cross protective responses.

View the original record at the funder ↗

Researchers

Bryan Charleston (EPMC Awardee)

Related Research

Grants with similar aims, by meaning.

Improved vaccine manufacture to control foot-and-mouth disease: Production of recombinant vaccines by design
Identifying epitopes that induce antibody mediated protection against foot-and-mouth disease using reverse genetics
The Molecular Biology of FMDV Replication: Towards New Methods of FMDV Disease Control.
Translation of virus like particle foot-and-mouth disease vaccine research to commercial development
Attenuation of FMDV Serotypes/Strains to Develop Stable and Effective Live, Attenuated, Vaccines

Original classification

Strategic Award - Innovations

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.